NO20030474L - Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddel - Google Patents
Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddelInfo
- Publication number
- NO20030474L NO20030474L NO20030474A NO20030474A NO20030474L NO 20030474 L NO20030474 L NO 20030474L NO 20030474 A NO20030474 A NO 20030474A NO 20030474 A NO20030474 A NO 20030474A NO 20030474 L NO20030474 L NO 20030474L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- active ingredient
- drug containing
- dementia drug
- oxodihydropurine derivatives
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 229940005524 anti-dementia drug Drugs 0.000 title 1
- 239000002664 nootropic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000230209 | 2000-07-31 | ||
| PCT/JP2001/006363 WO2002010167A1 (en) | 2000-07-31 | 2001-07-24 | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030474D0 NO20030474D0 (no) | 2003-01-30 |
| NO20030474L true NO20030474L (no) | 2003-03-27 |
Family
ID=18723200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030474A NO20030474L (no) | 2000-07-31 | 2003-01-30 | Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddel |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6962921B2 (cs) |
| EP (1) | EP1306378A4 (cs) |
| KR (1) | KR100829297B1 (cs) |
| CN (1) | CN1247578C (cs) |
| AU (1) | AU7278701A (cs) |
| BR (1) | BR0112881A (cs) |
| CA (1) | CA2416706C (cs) |
| CZ (1) | CZ2003234A3 (cs) |
| HK (1) | HK1054231A1 (cs) |
| HU (1) | HUP0303714A3 (cs) |
| IL (1) | IL154049A0 (cs) |
| MX (1) | MXPA03000861A (cs) |
| NO (1) | NO20030474L (cs) |
| NZ (1) | NZ523812A (cs) |
| PL (1) | PL363870A1 (cs) |
| RU (1) | RU2277096C2 (cs) |
| SK (1) | SK1292003A3 (cs) |
| WO (1) | WO2002010167A1 (cs) |
| ZA (1) | ZA200300549B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7760101B2 (en) * | 2008-06-20 | 2010-07-20 | Kimberly-Clark Worldwide, Inc. | Method of reducing sensor corrosion in absorbent articles |
| ES2626246T3 (es) * | 2009-09-09 | 2017-07-24 | Sumitomo Dainippon Pharma Co., Ltd. | Derivado de 8-oxodihidropurina |
| EP2718464A1 (en) | 2011-06-06 | 2014-04-16 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
| JPH06508836A (ja) * | 1991-06-26 | 1994-10-06 | セプラコア，インコーポレーテッド | 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物 |
| GB9208492D0 (en) * | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
| JP4667543B2 (ja) | 1996-07-03 | 2011-04-13 | 大日本住友製薬株式会社 | 新規プリン誘導体 |
| ZA9810490B (en) * | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| DE69932449T2 (de) * | 1998-12-18 | 2007-03-15 | Scios Inc., Fremont | Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs |
| WO2000037085A1 (en) * | 1998-12-18 | 2000-06-29 | Scios Inc. | Treatment of diseases involving cyst formation |
| JP3814125B2 (ja) * | 1999-06-02 | 2006-08-23 | 大日本住友製薬株式会社 | ２−アリール−８−オキソジヒドロプリン誘導体からなる医薬 |
-
2001
- 2001-07-24 RU RU2003105827/04A patent/RU2277096C2/ru not_active IP Right Cessation
- 2001-07-24 CN CNB018163742A patent/CN1247578C/zh not_active Expired - Fee Related
- 2001-07-24 MX MXPA03000861A patent/MXPA03000861A/es active IP Right Grant
- 2001-07-24 WO PCT/JP2001/006363 patent/WO2002010167A1/ja not_active Ceased
- 2001-07-24 HK HK03106435.7A patent/HK1054231A1/en unknown
- 2001-07-24 IL IL15404901A patent/IL154049A0/xx unknown
- 2001-07-24 HU HU0303714A patent/HUP0303714A3/hu unknown
- 2001-07-24 US US10/343,453 patent/US6962921B2/en not_active Expired - Fee Related
- 2001-07-24 CZ CZ2003234A patent/CZ2003234A3/cs unknown
- 2001-07-24 SK SK129-2003A patent/SK1292003A3/sk unknown
- 2001-07-24 BR BR0112881-7A patent/BR0112881A/pt not_active IP Right Cessation
- 2001-07-24 KR KR1020037001365A patent/KR100829297B1/ko not_active Expired - Fee Related
- 2001-07-24 CA CA002416706A patent/CA2416706C/en not_active Expired - Fee Related
- 2001-07-24 NZ NZ523812A patent/NZ523812A/en unknown
- 2001-07-24 AU AU7278701A patent/AU7278701A/xx not_active Withdrawn
- 2001-07-24 EP EP01951985A patent/EP1306378A4/en active Pending
- 2001-07-24 PL PL01363870A patent/PL363870A1/xx not_active Application Discontinuation
-
2003
- 2003-01-21 ZA ZA200300549A patent/ZA200300549B/en unknown
- 2003-01-30 NO NO20030474A patent/NO20030474L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ523812A (en) | 2004-07-30 |
| WO2002010167A1 (en) | 2002-02-07 |
| CN1466587A (zh) | 2004-01-07 |
| MXPA03000861A (es) | 2004-04-05 |
| CA2416706A1 (en) | 2002-02-07 |
| ZA200300549B (en) | 2003-08-19 |
| KR20030019634A (ko) | 2003-03-06 |
| RU2277096C2 (ru) | 2006-05-27 |
| US6962921B2 (en) | 2005-11-08 |
| CN1247578C (zh) | 2006-03-29 |
| US20030166667A1 (en) | 2003-09-04 |
| KR100829297B1 (ko) | 2008-05-13 |
| NO20030474D0 (no) | 2003-01-30 |
| BR0112881A (pt) | 2003-07-01 |
| EP1306378A4 (en) | 2005-02-09 |
| HUP0303714A2 (hu) | 2004-03-01 |
| PL363870A1 (en) | 2004-11-29 |
| IL154049A0 (en) | 2003-07-31 |
| EP1306378A1 (en) | 2003-05-02 |
| AU7278701A (en) | 2002-02-13 |
| HK1054231A1 (en) | 2003-11-21 |
| CZ2003234A3 (cs) | 2003-05-14 |
| HUP0303714A3 (en) | 2007-03-28 |
| CA2416706C (en) | 2009-04-07 |
| SK1292003A3 (en) | 2003-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ3227A1 (fr) | Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees | |
| ITTO20010008A0 (it) | Formulazione farmaceutica | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| FR2804025B1 (fr) | Compositions pharmaceutiques stabilisees | |
| NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
| NO20042807L (no) | Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| EE05376B1 (et) | Vesisuspensioonip?hineÁparenteraalneÁravimpreparaatÁjaÁsedaÁsisaldavÁviaal | |
| NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
| NO20020976D0 (no) | Retarderte, orale, farmasöytiske administreringsformer | |
| EE05063B1 (et) | Bensamiididerivaati sisaldav farmatseutiline preparaat | |
| NO20032438L (no) | Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene | |
| NO20034149D0 (no) | Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| NO20025635L (no) | Anvendelse av biguanidderivater til fremstilling av et legemiddel som har en sarhelende virkning | |
| DK1268419T3 (da) | Farmaceutisk aktive pyrrolidinderivater som BAX-inhibitorer | |
| DK1624869T3 (da) | Doseringsform indeholdende pantoprazol som aktiv bestanddel | |
| NO20032614L (no) | Farmasöytisk sammensetning som har forbedret absorberbarhet | |
| IS2258B (is) | Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni | |
| DK1207881T3 (da) | Farmaceutisk middel omfattende et benzamidderivat som aktiv bestanddel | |
| FR2802423B1 (fr) | Compositions pharmaceutiques | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
| HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
| NO20054214D0 (no) | Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |